Pantas, Ralden E.
HRN: 26-46-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/02/2025
01/08/2025
IV
200mg
Q8
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes